Institutional investors purchased a net $28.7 thousand shares of OPXA during the quarter ended June 2014, and now own 4.46% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 17.5 Thousand shares of Opexa Therapeutics Inc